Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$4.99bn	n/a	n/a
MSBMesoblast	AU$2.73bn	n/a	n/a
PYCPYC Therapeutics	AU$1.27bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$1.02bn	n/a	n/a
CGSCogstate	AU$449.47m	30.44	0.7%
RACRacura Oncology	AU$448.43m	n/a	n/a
TTXTetratherix	AU$251.66m	n/a	n/a
PEBPacific Edge	NZ$275.98m	n/a	n/a
BXNBioxyne	AU$151.33m	17.62	n/a
NYRNyrada	AU$133.79m	n/a	n/a
DXBDimerix	AU$123.08m	n/a	n/a
ACWActinogen Medical	AU$121.10m	n/a	n/a
ILAIsland Pharmaceuticals	AU$117.04m	n/a	n/a
ATHAlterity Therapeutics	AU$108.75m	n/a	n/a
IMMImmutep	AU$88.42m	n/a	n/a
PTXPrescient Therapeutics	AU$86.22m	n/a	n/a
ALAArovella Therapeutics	AU$84.08m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$72.85m	n/a	n/a
LTPLtr Pharma	AU$69.93m	n/a	n/a
ATXAmplia Therapeutics	AU$66.70m	n/a	n/a